
MANÜ Telehealth review
Prices live behind intake
The homepage sells GLP-1s from $4 a day, while the intake screen puts semaglutide plans at $199 a month.
Our verdict
MANÜ Telehealth advertises two different daily prices for the same products in the same component: $4 a day on a narrow screen and $5 a day on a wide one. Neither is reachable from any plan the site publishes. Monthly figures appear on the public site in one place, the intake quiz, where semaglutide plans start at $199 and tirzepatide at $297. Spread over a thirty-day month, $199 works out near $6.60 a day, half again the headline. Both product pages carry no price whatsoever, and the plans and pricing routes render nothing without starting an intake.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 pricing
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Labs
- Not stated
- Availability
- 50 states
- LegitScript
- Claimed by provider
- Updated
- September 2026
What it is
A bilingual telehealth seller of compounded semaglutide and tirzepatide injections, with a nutrition line alongside. The whole site runs in English and Spanish, and the FAQ states provider and pharmacy coverage in all 50 states.
How it works
A patient qualification quiz opens with a nurse practitioner's message and a pricing note, then gates on state of residence before collecting health history. A licensed provider reviews and prescribes, and medication ships free from U.S. compounding pharmacies. Coverage is stated as nationwide, with the buyer's address confirmed during intake and a waitlist offered where it is not served.
Pricing transparency
Two sets of figures are published and they do not agree. The homepage promises GLP-1s from $4 a day on a narrow screen and from $5 a day on a wide one, with no term, product or plan attached to either. The quiz intro gives the real ladder: compounded semaglutide plans starting at $199 and compounded tirzepatide plans starting at $297, with full-dose plans at $299 and $397. Both product pages and both pricing routes publish nothing at all, so the $199 becomes visible only after an intake has begun.
Branded vs compounded
Compounded semaglutide and tirzepatide by injection, filled by U.S. compounding pharmacies that are not named. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing, and the site states that plainly in its own footer. Starter plans are sold as a one-month purchase, with a promotion covering semaglutide doses up to 1.25 mg and tirzepatide doses up to 5 mg.
Pros and watch-outs
What we like
- LegitScript approval displayed and linked for verification
- A four-rung plan ladder rather than a single headline rate
- Full English and Spanish versions of the entire site
- Its own FDA disclaimer stated in plain language
Watch-outs
- Two different daily prices for the same products
- No monthly price on either product page
- The plan ladder appears only inside the intake quiz
- The compounding pharmacies are not named
Best for
Spanish-speaking buyers willing to start an intake for a price.
Who should look elsewhere
Anyone who wants a monthly figure printed on the product page.
How MANÜ Telehealth compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Luma Meds
New GLP-1 patients prepaying quarterly
See Luma Meds → Lumora
Comparing injection versus sublingual pricing
See Lumora →- LVNG RX
Flat-rate injection plan pricing
See LVNG RX →
More GLP-1 sellers by price reviews: FoundGalaHealthRXLive VitalMEDGmOak
Evidence & trials · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of MANÜ Telehealth’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does MANÜ Telehealth charge for semaglutide?
- Compounded semaglutide plans start at $199, with a full-dose plan at $299. Those figures appear in the intro screen of the qualification quiz rather than on the semaglutide product page, which publishes no price at all. Tirzepatide runs on the same structure, at $297 and $397.
- Is it really $4 a day?
- No plan on the site supports that figure. The homepage shows $4 a day on a narrow screen and $5 a day on a wide one, for the same products, with no term attached to either. Its opening monthly plan, $199, works out closer to $6.60 a day over a thirty-day month.
- Which states does MANÜ serve?
- The FAQ states licensed providers and pharmacy coverage in all 50 states, adding that coverage can change as the provider network and pharmacy licensing evolve. The quiz still gates on state of residence and has a path for states it does not serve, with a waitlist offered there. Coverage is therefore confirmed at intake rather than guaranteed up front.
- Is the medication FDA-approved?
- No. MANÜ dispenses compounded GLP-1s and says so in its footer, noting that while the pharmacies are regulated, the FDA has not evaluated these medications for safety, quality or efficacy. Compounded drugs are not FDA-approved and are not reviewed by the FDA before dispensing. The individual pharmacies are not identified.
- Is MANÜ Telehealth legit?
- MANÜ Telehealth is a GLP-1 sellers by price service. Its stated availability: 50 states. It displays a LegitScript certification claim, which we record as a claim and not as a verified fact: LegitScript's public checker is gated and returns the same page for any domain put into it, so no one can reproduce a check from it. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is MANÜ Telehealth expensive compared with other GLP-1 sellers by price providers?
- MANÜ Telehealth publishes a starting figure of $199/mo. Across the 226 GLP-1 sellers by price providers we review that publish a single monthly figure, those run $76 to $449 with a median of $179, which puts MANÜ Telehealth above the median. The other 11 GLP-1 sellers by price providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.